Romain MODZELEWSKI
Fonction : Informaticien
Groupe : Quantif
Publications associées
- Evaluation of sarcopenia biomarkers in older patients undergoing major surgery for digestive cancer.
Eur J Surg Oncol · 2023 - Impact of EGFRA289T/V mutation on relapse pattern in glioblastoma.
ESMO Open · 2023 - Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx Cancers.
Cancers (Basel) · 2023 - Assessing Interobserver Variability in the Delineation of Structures in Radiation Oncology: A Systematic Review.
Int J Radiat Oncol Biol Phys. · 2023 - Prediction of brain tumor recurrence location based on multi-modal fusion and nonlinear correlation learning.
Comput Med Imaging Graph. · 2023 - Deep learning analysis of contrast-enhanced spectral mammography to determine histoprognostic factors of malignant breast tumours.
Eur Radiol · 2022 - Multi-task multi-scale learning for outcome prediction in 3D PET images.
Comput Biol Med · 2022 - Clinical and phantom validation of a deep learning based denoising algorithm for F-18-FDG PET images from lower detection counting in comparison with the standard acquisition.
EJNMMI Phys · 2022 - Weakly Supervised Tumor Detection in PET Using Class Response for Treatment Outcome Prediction.
J Imaging · 2022 - [What dose escalation in the treatment of locally advanced non-small cell lung cancer?].
Cancer Radiother · 2022 - First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer.
First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer. · 2021 - Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma.
Front Cell Dev Biol · 2021 - Evaluation of an Automatic Classification Algorithm Using Convolutional Neural Networks in Oncological Positron Emission Tomography.
Front Med (Lausanne) · 2021 - Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC.
Sci Rep · 2021 - Multi-task deep learning based CT imaging analysis for COVID-19 pneumonia: Classification and segmentation.
Comput Biol Med · 2020 - Comparison of hypermetabolic and hypoxic volumes delineated on [18F] FDG an [18F] Fluoromisonidazole PET/CT in non-smal-cell lung cancer patients.
Mol Imaging Biol · 2020 - Development of 111-In-Labelled DOTA urotensin II analogues for targeting the UT receptor overexpressed in solid tumours.
Biomolecules · 2020 - How to work together between nuclear medicine and radiotherapy departments ?
Cancer Radiother · 2020 - Benefits of positron emission tomography scans for the evaluation of radiotherapy.
Benefits of positron emission tomography scans for the evaluation of radiotherapy. · 2020 - Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer.
Radiat Oncol · 2020 - Impact de la sarcopénie sur la survie globale et la survie sans progression après radiothérapie ou chimioradiothérapie pour le carcinome épidermoïde de la tête et du cou.
Cancer Radiother · 2020 - Radiotherapy boost in patients with hypoxic lesions identified by F-FMISO PET/CT in non small cell lung carcinoma : can we expect a better survival outcome without toxicity ? (RTEP5 study).
EJNMMI · 2019 - Comparison of hypermetabolic and hypoxic volumes delineated on 18FDG an 18Fmisonidazole PET-CT in non-small cell lung cancer patients.
Mol Imaging Biol · 2019 - 3D RPET-NET: Development of a 3D PET Imaging Convolutional Neural Network for Radiomics Analysis and Outcome Prediction.
2019 - Définition of target volume: when et how can the radiation oncologist use PET?
Cancer Radiother;23(6-7) :745-752. · 2019